Results 201 to 210 of about 130,060 (307)

Skin ulcer and maculopapular rash with inguinal lymph node enlargement: a case report of a 46-year-old female patient from north-eastern Poland with <i>Rickettsia</i> spp. and <i>Francisella tularensis</i> co-infection. [PDF]

Cent Eur J Immunol
Borawski K, Lebensztejn A, Czupryna P, Kondrusik M, Pancewicz S, Adamczuk J, Chmielewski T, Moniuszko-Malinowska A.   +7 more
europepmc   +1 more source

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

The effect of topical 0.5% humic acid gel on male rats with skin ulcer. [PDF]

J Cutan Aesthet Surg
Samiee-Rad F, Ghasemi F, Bahadoran E, Sofiabadi M, Shalbaf Z, Taherkhani A, Gheibi N.   +6 more
europepmc   +1 more source

Evaluation of Healing Effects of Poultice Containing 0.5% Fulvic Acid on Male White-Male Rats with Skin Ulcer.

J Cutan Aesthet Surg, 2022
Samiee-Rad F, Hosseini Sedighi SF, Taherkhani A, Gheibi N.   +3 more
europepmc   +1 more source

Self-caused skin ulcers

Psychosomatics, 1977
openaire   +2 more sources

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

British Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar, Malede Mequanent Sisay, Leonardo Roque‐Pereira, Christine Leopold, Patrick C. Souverein, Aukje K. Mantel‐Teeuwisse, Marie L. De Bruin   +6 more
wiley   +1 more source

[Mechanism of cold atmospheric plasma in treatment of chronic skin ulcer]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Yuan N, Yang Y, Tan C, Ran X.
europepmc   +1 more source

Severe Skin Ulcer on the Hand Caused by Hemodialysis Shunt-related Venous Hypertension That Required a Skin Graft. [PDF]

Plast Reconstr Surg Glob Open, 2020
Kuwahara M, Yoneda T.
europepmc   +1 more source

First‐in‐human, phase I, randomized, safety, pharmacokinetic, food‐effect and pharmacodynamic study of a tyrosine kinase 2/Janus kinase 1 inhibitor, SDC‐1801

British Journal of Clinical Pharmacology, EarlyView.
Aim The purpose of this study is to evaluate safety, tolerability, pharmacokinetics (PK), food‐effect (FE) and pharmacodynamics (PD) of an oral tyrosine kinase‐2 (TYK2)/Janus kinase‐1 (JAK1) inhibitor, SDC‐1801, in healthy adult participants. Methods This first‐in‐human study randomized 95 male and female participants.
Chris Brearley, Sam Francis, John Reader, Judi Proctor   +3 more
wiley   +1 more source

Progression of Skin Ulcer Secondary to Calciphylaxis in a Patient With End-Stage Renal Disease (ESRD) on Hemodialysis and the Therapeutic Approach. [PDF]

Cureus
Al-Khazraji Y, Al-Khazraji M, Oluaderounmu O, Quintanilla B.   +3 more
europepmc   +1 more source